Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3 Avadel Pharmaceuticals Plc

17th Nov 2025 13:42

RNS Number : 8474H
Tudor Capital Europe LLP
17 November 2025
 

 

Ap27

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

(a) Full name of discloser

Tudor Investment Corporation

(b) Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

Avadel Pharmaceuticals Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

N/A

(e) Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

14/11/2025

(f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. INTERESTS AND SHORT POSITIONS

 

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

 

Ap28

 

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

 

Class of relevant security (Note 3)

$0.01 ordinary shares

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled

938,605

0.9637

17,213

0.0177

(2) Cash-settled derivatives

2,798

0.0029

(3) Stock-settled derivatives (including options) and agreements to purchase/ sell

2,300

0.0024

1,293,200

1.3277

Total

940,905

0.9660

1,313,211*

1.3483

 

*Internal transfers led to the total 'Interests' and 'Short Positions' figures indicated here.

 

 

All interests and all short positions should be disclosed.

 

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevantsecurity

Purchase/sale

Number ofsecurities

Price per unit (Note 5)

Ordinary

Sale

5000

22.66781

Ordinary

Sale

5000

22.6992

Ordinary

Sale

50000

22.902648

Ordinary

Sale

73055

22.90359

Ordinary

Sale

1945

22.95

Ordinary

Sale

25000

22.953542

Ordinary

Sale

25000

22.974998

Ordinary

Sale

25000

22.984216

Ordinary

Sale

25000

23

Ordinary

Sale

25000

23.000299

Ordinary

Sale

50000

23.003986

Ordinary

Sale

51000

23.029212

Ordinary

Sale

25000

23.058045

Ordinary

Sale

25000

23.059774

Ordinary

Sale

25000

23.06

Ordinary

Sale

70000

23.091433

Ordinary

Sale

10000

23.1101

Ordinary

Sale

25000

23.115

Ordinary

Sale

25000

23.117452

Ordinary

Sale

49000

23.121954

Ordinary

Sale

25000

23.122393

Ordinary

Sale

25000

23.150945

Ordinary

Sale

25000

23.203761

Ordinary

Sale

50000

23.21019

Ordinary

Sale

10000

23.25

Ordinary

Sale

10000

23.2506

Ordinary

Sale

50000

23.27

Ordinary

Sale

100000

23.275

Ordinary

Sale

25000

23.296379

Ordinary

Sale

50000

23.3

Ordinary

Sale

10000

23.300721

Ordinary

Sale

25000

23.303981

Ordinary

Sale

50000

23.306628

Ordinary

Sale

10000

23.31052

Ordinary

Sale

25000

23.317338

Ordinary

Sale

50000

23.337142

Ordinary

Sale

25000

23.34142

Ordinary

Sale

50000

23.345604

Ordinary

Sale

50000

23.347233

Ordinary

Sale

25000

23.35002

Ordinary

Sale

50000

23.35006

Ordinary

Sale

25000

23.350402

Ordinary

Sale

50000

23.351629

Ordinary

Sale

50000

23.351842

Ordinary

Sale

50000

23.352644

Ordinary

Sale

25000

23.353278

Ordinary

Sale

50000

23.353767

Ordinary

Sale

25000

23.355686

Ordinary

Sale

50000

23.356372

Ordinary

Sale

10000

23.36

Ordinary

Sale

50000

23.369015

Ordinary

Sale

10000

23.4

Ordinary

Sale

25000

23.436471

Ordinary

Sale

25000

23.475334

Ordinary

Sale

25000

23.495

Ordinary

Sale

25000

23.5

Ordinary

Sale

25000

23.504672

Ordinary

Sale

25000

23.505696

Ordinary

Sale

50000

23.553355

Ordinary

Sale

200

22.92

Ordinary

Sale

100

22.93

Ordinary

Sale

100

22.94

Ordinary

Sale

400

22.95

Ordinary

Sale

100

22.9624

Ordinary

Sale

200

22.97

Ordinary

Sale

200

22.9782

Ordinary

Sale

100

22.9852

Ordinary

Sale

100

22.99

Ordinary

Sale

100

22.9914

Ordinary

Sale

100

22.9922

Ordinary

Sale

100

22.9936

Ordinary

Sale

100

22.9957

Ordinary

Sale

100

22.9958

Ordinary

Sale

100

22.9979

Ordinary

Sale

100

22.9982

Ordinary

Sale

100

22.9994

Ordinary

Sale

180

23

Ordinary

Sale

100

23.0247

Ordinary

Sale

200

23.0423

Ordinary

Sale

100

23.05

Ordinary

Sale

100

23.06

Ordinary

Sale

4

23.07

Ordinary

Sale

1

23.08

Ordinary

Sale

2

23.09

Ordinary

Sale

11607

23.1

Ordinary

Sale

300

23.105

Ordinary

Sale

1001

23.11

Ordinary

Sale

8221

23.12

Ordinary

Sale

400

23.13

Ordinary

Sale

101

23.15

Ordinary

Sale

2600

23.17

Ordinary

Sale

500

23.18

Ordinary

Sale

2

23.215

Ordinary

Sale

2900

23.2268

Ordinary

Sale

137

23.2279

Ordinary

Sale

40

23.2391

Ordinary

Sale

227

23.25

Ordinary

Sale

1175

23.26

Ordinary

Sale

100

23.2609

Ordinary

Sale

800

23.2629

Ordinary

Sale

10

23.2638

Ordinary

Sale

678

23.265

Ordinary

Sale

500

23.2687

Ordinary

Sale

300

23.2784

Ordinary

Sale

200

23.2788

Ordinary

Sale

100

23.2789

Ordinary

Sale

300

23.2793

Ordinary

Sale

200

23.2796

Ordinary

Sale

500

23.2867

Ordinary

Sale

300

23.2944

Ordinary

Sale

7

23.2999

Ordinary

Sale

50

23.3059

Ordinary

Sale

10

23.3065

Ordinary

Sale

30

23.3078

Ordinary

Sale

732

23.31

Ordinary

Sale

20

23.3128

Ordinary

Sale

200

23.313

Ordinary

Sale

68

23.315

Ordinary

Sale

2560

23.3152

Ordinary

Sale

10

23.3185

Ordinary

Sale

600

23.32

Ordinary

Sale

100

23.3255

Ordinary

Sale

1900

23.3279

Ordinary

Sale

1300

23.33

Ordinary

Sale

488

23.34

Ordinary

Sale

10

23.3423

Ordinary

Sale

776

23.345

Ordinary

Sale

408

23.3495

Ordinary

Sale

1345

23.35

Ordinary

Sale

76

23.3508

Ordinary

Sale

300

23.355

Ordinary

Sale

38

23.3555

Ordinary

Sale

69

23.3558

Ordinary

Sale

84

23.357

Ordinary

Sale

25

23.3584

Ordinary

Sale

44

23.359

Ordinary

Sale

19

23.3595

Ordinary

Sale

1403

23.36

Ordinary

Sale

152

23.365

Ordinary

Sale

45

23.37

Ordinary

Sale

445

23.38

Ordinary

Sale

2

23.41

Ordinary

Sale

11

23.42

Ordinary

Sale

4

23.445

Ordinary

Sale

2

23.45

Ordinary

Sale

15

23.46

Ordinary

Sale

3

23.47

Ordinary

Purchase

6

22.94

Ordinary

Purchase

2

23.03

Ordinary

Purchase

2

23.04

Ordinary

Purchase

10

23.05

Ordinary

Purchase

2

23.06

Ordinary

Purchase

3

23.07

Ordinary

Purchase

1

23.08

Ordinary

Purchase

3

23.09

Ordinary

Purchase

2

23.15

Ordinary

Purchase

2

23.16

Ordinary

Purchase

1

23.18

Ordinary

Purchase

1

23.19

Ordinary

Purchase

3

23.22

Ordinary

Purchase

3

23.25

Ordinary

Purchase

5

23.26

Ordinary

Purchase

3

23.27

Ordinary

Purchase

2

23.28

Ordinary

Purchase

2

23.29

Ordinary

Purchase

1

23.3

Ordinary

Purchase

2

23.31

Ordinary

Purchase

5

23.32

Ordinary

Purchase

6

23.33

Ordinary

Purchase

9

23.34

Ordinary

Purchase

17

23.35

Ordinary

Purchase

6

23.36

Ordinary

Purchase

4

23.37

Ordinary

Purchase

2

23.38

Ordinary

Purchase

1

23.41

Ordinary

Purchase

10

23.43

Ordinary

Purchase

10

23.44

Ordinary

Purchase

1

23.45

Ordinary

Purchase

20

23.46

Ordinary

Purchase

15

23.48

Ordinary

Purchase

1

23.49

Ordinary

Purchase

16

23.5

Ordinary

Purchase

22

23.51

Ordinary

Purchase

9

23.515

Ordinary

Purchase

5

23.52

Ordinary

Purchase

10

23.54

 

 

 

Ap29

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description e.g. CFD

Nature of dealing e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number of reference securities (Note 6)

Price per unit (Note 5)

 N/A

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates (Note 6)

Exerciseprice per unit

Type e.g. American, Europeanetc.

Expiry date

Option moneypaid/ received per unit

N/A

 

 

(ii) Exercise

 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit (Note 5)

N/A

 

 

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 3)

 

Class of relevant security

Nature of dealing e.g. subscription, conversion, exercise

Details

Price per unit (if applicable) (Note 5)

 N/A

 

 

 

 

Ap30

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 None

 

(c) Attachments

 

Is a Supplemental Form 8 attached?

YES/NO

 

Date of disclosure

17/11/2025

Contact name

Ben Kitchener

Telephone number

+44 (203) 755-3935

 

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

 

Ap31

 

NOTES ON FORM 8.3

 

1. See the definition of "connected fund manager" in Rule 2.2 of Part A of the Rules.

 

2. See the definition of "interest in a relevant security" in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of Part B of the Rules.

 

3. See the definition of "relevant securities" in Rule 2.1 of Part A of the Rules.

 

4. See the definition of "dealing" in Rule 2.1 of Part A of the Rules.

 

5. If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given.

 

6. See Rule 2.5(d) of Part A of the Rules.

 

7. If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.

 

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

 

References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

 

Ap32

 

SUPPLEMENTAL FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) ANDRULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,TAKEOVER RULES, 2022

 

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDINGOPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ANDRIGHTS TO SUBSCRIBE FOR NEW SECURITIES

 

1. KEY INFORMATION

 

Full name of person making disclosure:

Tudor Investment Corporation

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

Avadel Pharmaceuticals Plc

 

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

 

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities towhich optionor derivative relates

Exercise price per unit

Type e.g. American, European etc.

Expiry date

Equity Option

 Put Option

Purchased

1,000

10

American

16.01.2026

Equity Option

Call Option

Purchased

600

15

American

16.01.2026

Equity Option

Call Option

Purchased

600

17.5

American

16.01.2026

Equity Option

Put Option

Purchased

1,700

12.5

American

20.03.2026

Equity Option

Call Option

Purchased

200

15

American

20.03.2026

Equity Option

Put Option

Purchased

400

15

American

20.03.2026

Equity Option

Call Option

Purchased

800

17.5

American

20.03.2026

Equity Option

Put Option

Purchased

100

17.5

American

20.03.2026

Equity Option

Call Option

Purchased

100

20

American

20.03.2026

Equity Option

Put Option

Purchased

1,290,000

5

American

16.01.2026

 

3. AGREEMENTS TO PURCHASE OR SELL

 

Full details should be given so that the nature of the interest or position can be fully understood:

N/A

 

 

Ap33

 

4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS' AND OTHER EMPLOYEE OPTIONS)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

 

The currency of all prices and other monetary amounts should be stated.

 

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

 

References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ITPPKOBQNBDDKDD
FTSE 100 Latest
Value9,675.43
Change-22.94